Patent Assignment
Reel/Frame 049198/0414
Change of Name
Recorded: 2019-05-16
Pages: 2
Assignor
ARK THERAPEUTICS, LTD.
Executed: 2013-04-26
Assignee
FINVECTOR VISION THERAPIES LTD.
SANDERUM HOUSE, OAKLEY ROAD, CHINNOR, OXFORDSHIRE, OX39 4TW, UNITED KINGDOM
Covered Properties
(3)
Use of Inhibitors of the Renin-Angiotensin System
Use of inhibitors of the renin-angiotensin system
Application:
11/118,824 →
Publication:
US 2005/0192326
Use of Inhibitors of the Renin-Angiotensin System
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jul 14, 2003
From: EUROGENE LIMITED
To: ARK THERAPEUTICS LIMITED
Reel/Frame 013797/0292 →
Assignment of Assignor's Interest
Aug 3, 2005
From: ARK THERAPEUTICS LTD.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 016348/0481 →
Assignment of Assignor's Interest
Feb 2, 2009
From: MONTGOMERY, HUGH EDWARD; MARTIN, JOHN FRANCIS; ERUSALIMSKY, JORGE DANIEL
To: ARK THERAPEUTICS, LTD.
Reel/Frame 022186/0445 →
Assignment of Assignor's Interest
Mar 11, 2009
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: ARK THERAPEUTICS, LTD.
Reel/Frame 022374/0724 →
Assignment of Assignor's Interest
Apr 23, 2012
From: MONTGOMERY, HUGH EDWARD; MARTIN, JOHN FRANCIS; ERUSALIMSKY, JORGE DANIEL
To: ARK THERAPEUTICS LIMITED
Reel/Frame 028087/0832 →
Change of Name
May 16, 2019
From: FINVECTOR VISION THERAPIES LTD.
To: TRIZELL LTD.
Reel/Frame 049198/0498 →
Security Interest
Nov 19, 2020
From: TRIZELL LTD.
To: PHARMACEUTICAL PATENT ATTORNEYS, LLC
Reel/Frame 054775/0546 →
Release of Security Interest
Jan 31, 2022
From: PHARMACEUTICAL PATENT ATTORNEYS, LLC
To: TRIZELL LTD., F/K/A FINVECTOR LTD. F/K/A ARK THERAPEUTICS LTD.
Reel/Frame 058826/0044 →